JPMorgan Chase & Co. Acquires Shares of 429,990 BiomX Inc. (NYSEMKT:PHGE)

JPMorgan Chase & Co. acquired a new position in shares of BiomX Inc. (NYSEMKT:PHGE) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 429,990 shares of the company’s stock, valued at approximately $314,000.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “buy” rating and issued a $21.00 price target on shares of BiomX in a report on Friday, April 4th.

BiomX Stock Performance

Shares of PHGE opened at $0.58 on Friday. The firm has a market cap of $14.37 million, a P/E ratio of -0.77 and a beta of 1.51. BiomX Inc. has a twelve month low of $0.48 and a twelve month high of $4.90. The company has a debt-to-equity ratio of 0.51, a quick ratio of 2.84 and a current ratio of 2.84. The firm’s 50 day moving average price is $0.59 and its two-hundred day moving average price is $0.69.

BiomX Profile

BiomX Inc, a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis.